Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Real-world effectiveness and safety of pharmacological thromboprophylaxis in patients undergoing primary total hip and knee arthroplasty: A narrative review

Research output: Contribution to journalReviewResearchpeer-review

  1. MRi of the knee compared to specialized radiography for measurements of articular cartilage height in knees with osteoarthritis

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Temporal trends in utilization of transcatheter aortic valve replacement and patient characteristics: a nationwide study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Diabetes increases the risk of bone fractures in patients on kidney replacement therapy: A DANISH national cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Thromboembolic and bleeding complications following primary total knee arthroplasty: a Danish nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Using machine learning for predicting intensive care unit resource use during the COVID-19 pandemic in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Duloxetine Exposure During Pregnancy and the Risk of Spontaneous and Elective Abortion: A Danish Nationwide Observational Study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

In this narrative review of the real-world effectiveness and safety of pharmacological thromboprophylaxis following primary total hip and knee arthroplasty, a total of 12 non-interventional observational studies were included. Pharmacological thromboprophylaxis included warfarin, heparins, dabigatran, rivaroxaban, apixaban, acetylsalicylic acid, and fondaparinux. The absolute risks varied across the included studies. These variations can be explained by differences in patient populations, drug exposure, follow-up time, and definition of outcomes, which makes it a challenge to compare the risk estimates. These findings emphasize the need for a large population-based real-world study to provide comparable risk estimates associated with different pharmacological thromboprophylaxis.

Original languageEnglish
Article numberhttps://doi.org/10.1016/j.jor.2019.11.012
JournalJournal of Orthopaedics
Volume19
Pages (from-to)166-173
Number of pages8
ISSN0972-978X
DOIs
Publication statusPublished - 7 Feb 2020

    Research areas

  • Drug effectiveness, Drug safety, Pharmacological thromboprophylaxis, Total hip arthroplasty, Total knee arthroplasty

ID: 58644597